Conditions: Hepatitis C
Allocation: RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 32
Healthy volunteers: no

Brief summary:
Assess the safety, tolerability and pharmacokinetics of multiple oral doses of PF-00868554 in HCV positive patient volunteers

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None arm 5: None

Interventions: intervention 1: PF-00868554 intervention 2: PF-00868554 intervention 3: PF-00868554 intervention 4: PF-00868554 intervention 5: Placebo
Intervention descriptions: intervention 1: 300 mg BID intervention 2: 450 mg BID intervention 3: 100 mg BID intervention 4: 300 mg TID intervention 5: Placebo

Protocol document: